Viewing Study NCT01883505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-02-09 @ 1:18 AM
Study NCT ID: NCT01883505
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2013-06-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
Sponsor: NeuroDerm Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Motor fluctuations View
None levodopa pharmacokinetics View
None levodopa and carbidopa solution View
None continuous subcutaneous delivery View
None Patch-pump View